DRUGS MADE IN AMERICA ACQ-RT (DMIIR) Stock Price & Overview

NASDAQ:DMIIR

Current stock price

0.085 USD
0 (-5.56%)
Last:

The current stock price of DMIIR is 0.085 USD. Today DMIIR is down by -5.56%. In the past month the price decreased by -22.73%.

DMIIR Key Statistics

1-Month Range0.0661 - 0.13
Current DMIIR stock price positioned within its 1-month range.
Market Cap
5.574M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.01
Dividend Yield
N/A

DMIIR Stock Performance

Today
-5.56%
1 Week
+6.25%
1 Month
-22.73%
3 Months
-26.34%
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

DMIIR Stock Chart

DRUGS MADE IN AMERICA ACQ-RT / DMIIR Daily stock chart

DMIIR Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to DMIIR.


Chartmill TA Rating
Chartmill Setup Rating
DMIIR Full Technical Analysis Report

DRUGS MADE IN AMERICA ACQ-RT / DMIIR FAQ

Can you describe the business of DRUGS MADE IN AMERICA ACQ-RT?

Drugs Made In America Acquisition II Corp. operates as a blank check company. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. While the Company may pursue a business combination target in any business, industry or geographical location, it intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenue to date.


What is the stock price of DRUGS MADE IN AMERICA ACQ-RT today?

The current stock price of DMIIR is 0.085 USD. The price decreased by -5.56% in the last trading session.


How is the ChartMill rating for DRUGS MADE IN AMERICA ACQ-RT?

DMIIR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is DMIIR stock listed?

DMIIR stock is listed on the Nasdaq exchange.